Advertisement
Screener

CASTLE BIOSCIENCES, INC. (CSTL) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

CASTLE BIOSCIENCES, INC. Cash Flow Breakdown

Cash flow breakdown shows where CASTLE BIOSCIENCES, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $64.35M came in.
  • Fiscal year ended 2025-12-31: from investing, $60.37M went out.
  • Fiscal year ended 2025-12-31: from financing, $6.96M went out.
  • Fiscal year ended 2025-12-31: change in cash, $2.98M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2025-12-31$64.35M-$60.37M-$11.66M$2.21M$2.49M*-$2.98M
2024-12-31$64.87M-$50.14M-$8.76M$2.02M$12.88M*$20.87M
2023-12-31-$5.63M-$16.18M-$5.13M$269.00K$2.57M*-$24.11M
2022-12-31-$41.66M-$166.54M-$1.69M$833.00K$2.37M*-$206.69M
2021-12-31-$18.98M-$66.66M-$781.00K$4.23M$1.97M*-$80.22M
2020-12-31$9.87M-$4.75M$0.00$330.04M-$24.15M*$311.01M
2019-12-31$7.01M-$937.00K$65.93M$22.36M*$94.37M
2018-12-31-$12.29M-$277.00K$38.00K$15.80M*$3.27M

Each quarter (3 month)

Quarter endRunning the businessFrom investingStaff share taxNew shares soldNot split outChange in cash
2026-06-30$15.20M*-$15.96M*-$793.00K*$95.00K*
2026-03-31-$22.13M-$25.80M-$6.60M$322.00K$1.24M*-$52.97M
2025-12-31$26.93M*$8.83M*-$7.37M*$2.09M*$687.00K*
2025-09-30$22.63M*-$18.39M*-$1.19M*$77.00K*
2025-06-30$20.82M*-$28.38M*-$589.00K*$19.00K*
2025-03-31-$6.04M-$22.43M-$2.52M$18.00K$944.00K*-$30.02M
2024-12-31$24.36M*$5.77M*-$6.38M*$373.00K*$621.00K*
2024-09-30$23.34M*-$14.79M*-$1.29M*$1.57M*$561.00K*
2024-06-30$24.00M*-$21.42M*-$615.00K*$8.00K*
2024-03-31-$6.83M-$19.70M-$474.00K$65.00K$11.05M*-$15.89M
2023-12-31$18.59M*-$7.67M*-$4.01M*$72.00K*$646.00K*
2023-09-30$5.01M*-$9.71M*-$271.00K*$13.00K*
2023-06-30-$3.79M*-$15.39M*-$534.00K*$89.00K*
2023-03-31-$25.44M$16.58M-$314.00K$95.00K$947.00K*-$8.13M
2022-12-31-$6.00M*-$4.48M*-$1.55M*$158.00K*$646.00K*
2022-09-30-$5.22M*-$134.15M*-$46.00K*$166.00K*
2022-06-30-$9.00M*-$27.51M*-$32.00K*$110.00K*$583.00K*
2022-03-31-$21.43M-$402.00K-$56.00K$399.00K$873.00K*-$20.62M
2021-12-31-$2.78M*-$30.89M*-$781.00K*$366.00K*
2021-09-30-$6.13M*-$923.00K*$0.00*$1.52M*
2021-06-30-$6.44M*-$34.09M*$0.00*$1.35M*$537.00K*
2021-03-31-$3.63M-$750.00K$0.00$991.00K$519.00K*-$2.87M
2020-12-31-$430.00K*-$588.00K*$250.54M*-$22.72M*
2020-09-30-$2.96M*-$1.90M*$9.97M*-$1.82M*
2020-06-30$13.50M*-$1.76M*$329.00K*$69.03M*
2020-03-31-$251.00K-$500.00K$71.00K-$192.00K
2019-12-31$4.49M*-$347.00K*-$4.00K*
2019-09-30$752.00K*-$166.00K*$65.94M*$10.49M*
2019-06-30$482.00K*-$180.00K*$416.00K*$520.00K*
2019-03-31$1.29M-$244.00K$1.00K$10.71M*$11.75M
2018-12-31-$3.21M*-$5.38K*$304.00*$4.42M*
2018-09-30-$1.88M*-$87.01K*$36.63K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Personalis, Inc. (PSNL)United States$1.769B-13.30
BIODESIX INC (BDSX)United States$0.312B
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B